How chronic liver diseases connect with other long-term illnesses

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective observational analysis of electronic health records from the Buddhist Tzu Chi Medical Foundation hospital database. The project will identify patients with chronic liver conditions (hepatitis B, hepatitis C, alcoholic liver disease, fatty liver, cirrhosis, and hepatocellular carcinoma) and examine associations with other systemic diseases, disease progression, treatments, and outcomes. Investigators will extract diagnoses, comorbidities, laboratory data, and treatment histories and apply statistical methods to detect correlations and patterns. Results aim to clarify how liver dysfunction influences risks and prognosis in other organ systems and to identify high-risk patient groups.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals who visited the gastroenterology clinics of the Tzu Chi Hospitals, Buddhist Tzu Chi Medical Foundation

Exclusion Criteria:

* Age younger than 18 or older than 99 years

Where it's running

• Ching-Sheng Hsu
  New Taipei City, Taiwan Recruiting

Study contacts

• Principal investigator: Ching-Sheng Hsu, Ph.D — Liver Diseases Research Center, Taipei Tzu Chi Hospital
• Study coordinator: Ching-Sheng Hsu, Ph.D
• Email: hsu.chingsheng@gmail.com
• Phone: 886-979239381

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exploring the link between plasma sphingolipids and radiotherapy effectiveness in liver cancer

  This study is trying to see if the levels of certain fats in the blood can help predict how well radiotherapy works for people with liver cancer.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT06864221

• Predicting liver disease complications and cancer development in patients

  This study is testing if a new way of monitoring patients with advanced liver disease can help predict serious health issues and cancer better than standard care.

  Recruiting University Hospital Muenster · Münster, North Rhine-Westphalia · NCT06523608

• Screening for hepatitis B, hepatitis C and HIV using a dried blood spot

  This project will try a simple dried blood spot test to check people who use drugs for hepatitis B, hepatitis C and HIV.

  Recruiting at 11 sites University Hospital, Rouen · Avranches and 10 other locations · NCT05390424

• Collecting blood samples from healthy individuals and patients with cancer or benign diseases

  This study is collecting blood samples from healthy people and patients with cancer or non-cancer conditions to see if certain DNA markers can help detect cancer more accurately.

  Recruiting at 6 sites Helio Genomics · Redondo Beach, California and 6 other locations · NCT05181826

• Biorepository for liver disease samples

  This study is collecting samples from patients with liver diseases to help researchers find better treatments and improve care for these conditions.

  Recruiting State University of New York at Buffalo · Buffalo, New York · NCT03025074

• Evaluation of patients with liver disease

  This study is trying to learn more about liver diseases by checking in on patients with conditions like hepatitis B, C, and D through regular tests and follow-ups.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00001971

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.